Medpace (MEDP) closed at $354.65, down 0.57% from the day before, trailing S&P 500. Stock dropped 9.01% in the past month, underperforming Medical sector. Earnings release upcoming with projected EPS at $2.78, a 25.23% increase YoY. Zacks estimates full-year earnings at $11.66 per share and revenue of $2.13 billion.

Analysts have revised estimates for Medpace, reflecting short-term trends and confidence in the company’s performance. Zacks Rank system rates MEDP at #3 (Hold). Forward P/E ratio at 30.6, higher than industry average. PEG ratio at 1.85, higher than industry average of 1.66. Medical Services industry ranked 158 out of 250+ industries.

Investors can access Zacks’ picks for $1, no obligation. Services like Surprise Trader and Technology Innovators closed 228 positions with double- and triple-digit gains in 2023. Zacks Investment Research offers free stock analysis reports and recommendations. Visit Zacks.com for more stock-moving metrics and updates.

Read more at Nasdaq: Medpace (MEDP) Stock Dips While Market Gains: Key Facts